Top Differentiated Thyroid Cancer Therapeutics Companies, Leaders & Major Players

This list of the top companies of Differentiated Thyroid Cancer Therapeutics is drawn from assessments by Mordor Intelligence analysts and expert advisors via their extensive research to identify the brands, leaders and major players active in Differentiated Thyroid Cancer Therapeutics sector.

Top Differentiated Thyroid Cancer Therapeutics Companies

  1. Bayer

  2. Eisai

  3. Exelixis

  4. Sanofi

  5. Curium Pharma

*Disclaimer: Top companies sorted in no particular order

Differentiated Thyroid Cancer Therapeutics Market Major Players

Differentiated Thyroid Cancer Therapeutics - Competitive Concentration

Differentiated Thyroid Cancer Therapeutics Market Concentration

List of Differentiated Thyroid Cancer Therapeutics Companies

  • Bayer

  • Eisai

  • Exelixis

  • Sanofi

  • Jubilant Radiopharma

  • Curium Pharma

  • Eli Lilly & Co

  • AstraZeneca

  • Merck

  • Roche

  • Blueprint Medicines

  • Rosatom (JSC Isotope)

  • IBSA Pharma

  • GE HealthCare (MED radionuclides)

  • Siemens Healthineers (Theranostics)

  • Pfizer

  • Jiangsu Hengrui Pharma

  • Yantai InnoPharmchem

Complete your form and get your market insights delivered to your inbox

Takes less than 10 seconds